An Asia Hub: Novartis Plans Biotech Manufacturing Center In Singapore
This article was originally published in PharmAsia News
Novartis plans to build a new center of excellence for biotechnology manufacturing costing more than $500 million, as it looks to leverage Singapore’s skilled labor force and proximity to growth markets like China.
You may also be interested in...
In a vote, the panel expressed little confidence in the adequacy of the available evidence on whether there are clinically meaningful differences in outcomes among the anti-VEGF agents.